We Care. Research for your Health.

Press Releases Company 2004
= Information for professionals with login

The Importance of Treating Alzheimer’s Dementia (20 Dec 2004)
Merz presents Award for Brain Research in Geriatrics 2004 (24 Nov 2004)
Application to Expand Memantine Approval to Include Mild Stages of Alzheimer’s Disease (16 Nov 2004)
Application to Expand Memantine Approval to Include Mild Stages of Alzheimer’s Disease (16 Nov 2004)
Coma patients with severe craniocerebral trauma: significantly higher chances of survival with amantadine sulfate (PK-Merz®) infusions (10 Oct 2004)
Axura® (Memantine) Shows Benefits on Both Behavioral Disturbances and Activities of Daily Living in Patients with Moderate to Severe Alzheimer’s Disease (23 Jun 2004)
New Study Results Demonstrate Beneficial Effects of Axura® (Memantine) on Brain Activity in Patients with Mild to Moderate Alzheimer´s Disease (29 Apr 2004)
Memantine captures US market (20 Feb 2004)
Award for Brain Research (14 Jan 2004)
Merz Alzheimer drug effective in treating mild, moderate and severe Alzheimer’s disease (AD) (07 Jan 2004)
Memantine effective in treating mild, moderate and severe Alzheimer’s disease (AD) (07 Jan 2004)

Last update: 14 Mai 2007, 04:26

produced by GPM mbH